EP1475095A4 - Percutaneous preparations - Google Patents

Percutaneous preparations

Info

Publication number
EP1475095A4
EP1475095A4 EP03705125A EP03705125A EP1475095A4 EP 1475095 A4 EP1475095 A4 EP 1475095A4 EP 03705125 A EP03705125 A EP 03705125A EP 03705125 A EP03705125 A EP 03705125A EP 1475095 A4 EP1475095 A4 EP 1475095A4
Authority
EP
European Patent Office
Prior art keywords
percutaneous preparations
percutaneous
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03705125A
Other languages
German (de)
French (fr)
Other versions
EP1475095A1 (en
Inventor
Yasuhiro Tsuji
Kei Tamura
Yuuhiro Yamazaki
Yoshihiro Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyukyu Pharmaceutical Co Ltd
Original Assignee
Kyukyu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyukyu Pharmaceutical Co Ltd filed Critical Kyukyu Pharmaceutical Co Ltd
Publication of EP1475095A1 publication Critical patent/EP1475095A1/en
Publication of EP1475095A4 publication Critical patent/EP1475095A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03705125A 2002-02-14 2003-02-13 Percutaneous preparations Withdrawn EP1475095A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002037405 2002-02-14
JP2002037405 2002-02-14
JP2002381318 2002-12-27
JP2002381318 2002-12-27
PCT/JP2003/001502 WO2003068241A1 (en) 2002-02-14 2003-02-13 Percutaneous preparations

Publications (2)

Publication Number Publication Date
EP1475095A1 EP1475095A1 (en) 2004-11-10
EP1475095A4 true EP1475095A4 (en) 2008-07-23

Family

ID=27736502

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03705125A Withdrawn EP1475095A4 (en) 2002-02-14 2003-02-13 Percutaneous preparations

Country Status (7)

Country Link
US (2) US7820197B2 (en)
EP (1) EP1475095A4 (en)
KR (2) KR100998856B1 (en)
CN (1) CN1633300A (en)
AU (1) AU2003211963A1 (en)
TW (1) TW200306847A (en)
WO (1) WO2003068241A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090239828A1 (en) 2006-09-11 2009-09-24 Yuuhiro Yamazaki Adhesive preparation
WO2008039864A1 (en) * 2006-09-26 2008-04-03 Novavax, Inc. Emulsion formulations for transdermal delivery of poorly water soluble active agents
AR064263A1 (en) * 2006-11-17 2009-03-25 Besins Healthcare PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMPOSITE BISFOSFATO
EP1923050A1 (en) * 2006-11-17 2008-05-21 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
WO2008072869A1 (en) * 2006-12-12 2008-06-19 Ewha University Industry Collaboration Foundation Plaster composition comprising alendronate as an effective ingredient for treating osteoporosis
JP5328672B2 (en) * 2007-12-10 2013-10-30 コスメディ製薬株式会社 Transdermal absorption preparation
KR101760510B1 (en) 2014-12-18 2017-07-21 가톨릭대학교 산학협력단 Metformin-comprising compositions for reducing nephrotoxicity caused by immunosuppressive drugs and for the prevention or treatment of immune diseases
US10286095B2 (en) 2015-09-11 2019-05-14 Olson Ip Technologies, Inc. Travel kit
CN113694110A (en) * 2021-09-01 2021-11-26 深圳市资福药业有限公司 Incadronate disodium product and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
WO2000045795A2 (en) * 1999-02-05 2000-08-10 Cipla Limited Topical sprays comprising a film forming composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2649977A (en) 1976-07-15 1979-01-04 Procter & Gamble Pharmaceutical composition
JPH07629B2 (en) 1988-01-20 1995-01-11 山之内製薬株式会社 (Cycloalkylamino) methylenebis (phosphonic acid) and a drug containing the compound as an active ingredient
MX21452A (en) 1989-07-07 1994-01-31 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS THAT ARE TOPICALLY ADMINISTERED.
JP3226940B2 (en) 1990-05-30 2001-11-12 山之内製薬株式会社 Transdermal formulation
JPH0699457A (en) 1992-09-17 1994-04-12 Yoshida Kogyo Kk <Ykk> Manufacture of double-surface transfer-injection molded product, molding mold and injection molded product
JP3411690B2 (en) 1994-09-21 2003-06-03 帝人株式会社 Alendronate sodium preparation for topical administration
US6008206A (en) 1994-09-21 1999-12-28 Merck & Co., Inc. Sodium alendronate preparation for local administration
SE9703691D0 (en) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
US6896898B1 (en) * 1999-11-19 2005-05-24 Xel Herbaceuticals, Inc. Transdermal delivery system for alkaloids of aconitum species
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
WO2000045795A2 (en) * 1999-02-05 2000-08-10 Cipla Limited Topical sprays comprising a film forming composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03068241A1 *

Also Published As

Publication number Publication date
US20050106186A1 (en) 2005-05-19
KR20100063827A (en) 2010-06-11
CN1633300A (en) 2005-06-29
AU2003211963A1 (en) 2003-09-04
US20100055159A1 (en) 2010-03-04
WO2003068241A1 (en) 2003-08-21
US7820197B2 (en) 2010-10-26
EP1475095A1 (en) 2004-11-10
TW200306847A (en) 2003-12-01
KR100998856B1 (en) 2010-12-08
KR20040081791A (en) 2004-09-22

Similar Documents

Publication Publication Date Title
EP1552833A4 (en) Stable solid preparations
EP1437130A4 (en) Percutaneous absorption preparations
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
AU2003252028A8 (en) Heterodiamondoids
GB0207438D0 (en) Formulation
AU2003279495A8 (en) Alert-modeling
GB0205504D0 (en) Formulation
GB0213531D0 (en) Paper-to-computer interfaces
EP1475095A4 (en) Percutaneous preparations
AU2003216267A8 (en) Plant preparations
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003264900A8 (en) Cast-cutter
AU2003262681A8 (en) Hemo-aide
GB0214147D0 (en) Formulations
AU2003253735A8 (en) Vacuolins
GB0206776D0 (en) Majicup
GB0201601D0 (en) Fitted furniture aid
GB0215011D0 (en) Easy squeezy
GB0214771D0 (en) Dilating preparations
AU2002952694A0 (en) Zipper stopper
AU2002951199A0 (en) Zipper stopper
AU2329P (en) Gaula Gaura lindheimeri
AU2328P (en) Archley Arctotis fastuosa
AU2326P (en) Gavol Gazania rigens

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040720

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KYUKYU PHARMACEUTICAL CO., LTD.

Owner name: ASTELLAS PHARMA INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KYUKYU PHARMACEUTICAL CO., LTD.

A4 Supplementary search report drawn up and despatched

Effective date: 20080625

17Q First examination report despatched

Effective date: 20090114

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120901